Perry Sternberg
Director Ejecutivo en CORIUM INTERNATIONAL INC .
Fortuna: 339 811 $ al 31/05/2024
Perfil
Perry J.
Sternberg is currently the President, Chief Executive Officer & Director at Corium LLC, the President & Chief Executive Officer at Corium International, Inc., the Lead Independent Director at Harrow, Inc., and a Director at Surface Ophthalmics, Inc. Previously, he served as the Chief Executive Officer at Corium Pharma Solutions, Inc., the Head-Neuroscience Business Unit at Shire Plc, and the Vice President & General Manager at Bausch & Lomb, Inc. Mr. Sternberg obtained his undergraduate degree from The Pennsylvania State University in 1990.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
HARROW, INC.
0.05% | 16/04/2024 | 18 931 ( 0.05% ) | 339 811 $ | 31/05/2024 |
Cargos activos de Perry Sternberg
Empresas | Cargo | Inicio |
---|---|---|
CORIUM INTERNATIONAL INC | Director Ejecutivo | 02/04/2019 |
HARROW, INC. | Director/Miembro de la Junta | 31/03/2022 |
Surface Ophthalmics, Inc.
Surface Ophthalmics, Inc. BiotechnologyHealth Technology Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA. | Director/Miembro de la Junta | - |
Corium LLC
Corium LLC BiotechnologyHealth Technology Corium LLC is a commercial-stage biopharmaceutical company that specializes in developing and commercializing novel neuroscience therapies. Corium is based in Grand Rapid, MI, and the CEO of the private company is Perry J. Sternberg. The company provides clinicians with important treatment options for patients, their families, and their caregivers. | Director Ejecutivo | - |
Antiguos cargos conocidos de Perry Sternberg.
Empresas | Cargo | Fin |
---|---|---|
Corium Pharma Solutions, Inc.
Corium Pharma Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Corium Pharma Solutions, Inc. is a full-service contract development and manufacturing organization that specializes in novel drug and consumer product delivery technologies. The company is based in an undisclosed location. The American company offers end-to-end solutions to its partners, from formulation and product development work, through commercial-scale manufacturing and packaging. Corium Pharma Solutions has a track record spanning nearly 30 years and is jointly owned by B-Flexion and Webster Equity Partners. The company's success is enabled by its state-of-the-art facilities, highly tenured operational leadership, and proprietary drug delivery technologies, Corplex™ and MicroCor®. Mark A. Sirgo has been the CEO of the company since 2023. | Director Ejecutivo | 17/01/2023 |
SHIRE | Corporate Officer/Principal | 01/01/2019 |
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ Medical SpecialtiesHealth Technology Part of Amplifon SpA, Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ is an American company that manufactures and markets hearing aids and related products. Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business was acquired by Amplifon SpA from Bausch & Lomb, Inc. on August 30, 1999. | Corporate Officer/Principal | - |
Formación de Perry Sternberg.
The Pennsylvania State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
HARROW, INC. | Health Technology |
Empresas privadas | 6 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ Medical SpecialtiesHealth Technology Part of Amplifon SpA, Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ is an American company that manufactures and markets hearing aids and related products. Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business was acquired by Amplifon SpA from Bausch & Lomb, Inc. on August 30, 1999. | Health Technology |
Corium International, Inc.
Corium International, Inc. Pharmaceuticals: MajorHealth Technology Corium International, Inc. is a pharmaceutical company. It offers products such as corplex donepezil and memantine. The company was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Surface Ophthalmics, Inc.
Surface Ophthalmics, Inc. BiotechnologyHealth Technology Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA. | Health Technology |
Corium Pharma Solutions, Inc.
Corium Pharma Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Corium Pharma Solutions, Inc. is a full-service contract development and manufacturing organization that specializes in novel drug and consumer product delivery technologies. The company is based in an undisclosed location. The American company offers end-to-end solutions to its partners, from formulation and product development work, through commercial-scale manufacturing and packaging. Corium Pharma Solutions has a track record spanning nearly 30 years and is jointly owned by B-Flexion and Webster Equity Partners. The company's success is enabled by its state-of-the-art facilities, highly tenured operational leadership, and proprietary drug delivery technologies, Corplex™ and MicroCor®. Mark A. Sirgo has been the CEO of the company since 2023. | Commercial Services |
Corium LLC
Corium LLC BiotechnologyHealth Technology Corium LLC is a commercial-stage biopharmaceutical company that specializes in developing and commercializing novel neuroscience therapies. Corium is based in Grand Rapid, MI, and the CEO of the private company is Perry J. Sternberg. The company provides clinicians with important treatment options for patients, their families, and their caregivers. | Health Technology |
- Bolsa de valores
- Insiders
- Perry Sternberg